• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用专家增强机器学习预测慢加急性肝衰竭患者肝移植术后结局。

Predicting post-liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA.

Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.

出版信息

Am J Transplant. 2023 Dec;23(12):1908-1921. doi: 10.1016/j.ajt.2023.08.022. Epub 2023 Aug 30.

DOI:10.1016/j.ajt.2023.08.022
PMID:37652176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11018271/
Abstract

Liver transplantation (LT) is a treatment for acute-on-chronic liver failure (ACLF), but high post-LT mortality has been reported. Existing post-LT models in ACLF have been limited. We developed an Expert-Augmented Machine Learning (EAML) model to predict post-LT outcomes. We identified ACLF patients who underwent LT in the University of California Health Data Warehouse. We applied the RuleFit machine learning (ML) algorithm to extract rules from decision trees and create intermediate models. We asked human experts to rate the rules generated by RuleFit and incorporated these ratings to generate final EAML models. We identified 1384 ACLF patients. For death at 1 year, areas under the receiver-operating characteristic curve were 0.707 (confidence interval [CI] 0.625-0.793) for EAML and 0.719 (CI 0.640-0.800) for RuleFit. For death at 90 days, areas under the receiver-operating characteristic curve were 0.678 (CI 0.581-0.776) for EAML and 0.707 (CI 0.615-0.800) for RuleFit. In pairwise comparisons, both EAML and RuleFit models outperformed cross-sectional models. Significant discrepancies between experts and ML occurred in rankings of biomarkers used in clinical practice. EAML may serve as a method for ML-guided hypothesis generation in further ACLF research.

摘要

肝移植(LT)是治疗慢加急性肝衰竭(ACLF)的一种方法,但据报道 LT 后死亡率较高。现有的 ACLF 术后模型存在局限性。我们开发了一种专家增强机器学习(EAML)模型来预测 LT 后的结果。我们从加利福尼亚大学健康数据仓库中确定了接受 LT 的 ACLF 患者。我们应用 RuleFit 机器学习(ML)算法从决策树中提取规则并创建中间模型。我们请人类专家对 RuleFit 生成的规则进行评分,并将这些评分纳入最终的 EAML 模型中。我们确定了 1384 名 ACLF 患者。对于 1 年死亡率,EAML 的受试者工作特征曲线下面积为 0.707(置信区间 0.625-0.793),RuleFit 的面积为 0.719(置信区间 0.640-0.800)。对于 90 天死亡率,EAML 的受试者工作特征曲线下面积为 0.678(置信区间 0.581-0.776),RuleFit 的面积为 0.707(置信区间 0.615-0.800)。在两两比较中,EAML 和 RuleFit 模型均优于横截面模型。在用于临床实践的生物标志物的排名方面,专家和 ML 之间存在显著差异。EAML 可以作为在进一步的 ACLF 研究中使用 ML 指导假设生成的一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/d7f38b73f881/nihms-1981986-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/06d5bf046ef8/nihms-1981986-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/214080cfcdf2/nihms-1981986-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/d7f38b73f881/nihms-1981986-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/06d5bf046ef8/nihms-1981986-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/214080cfcdf2/nihms-1981986-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13c0/11018271/d7f38b73f881/nihms-1981986-f0003.jpg

相似文献

1
Predicting post-liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning.使用专家增强机器学习预测慢加急性肝衰竭患者肝移植术后结局。
Am J Transplant. 2023 Dec;23(12):1908-1921. doi: 10.1016/j.ajt.2023.08.022. Epub 2023 Aug 30.
2
Factors Prognostic of Survival in Liver Transplant Recipients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure.乙型肝炎病毒相关慢加急性肝衰竭肝移植受者生存预后的影响因素。
Can J Gastroenterol Hepatol. 2022 May 10;2022:6390809. doi: 10.1155/2022/6390809. eCollection 2022.
3
Value of Model for End-Stage Liver Disease-Serum Sodium Scores in Predicting Complication Severity Grades After Liver Transplantation for Acute-on-chronic Liver Failure.终末期肝病-血清钠评分模型在预测急性慢性肝衰竭肝移植术后并发症严重程度分级中的价值
Transplant Proc. 2019 Apr;51(3):833-841. doi: 10.1016/j.transproceed.2019.01.027. Epub 2019 Jan 9.
4
Models to predict the short-term survival of acute-on-chronic liver failure patients following liver transplantation.预测肝移植后慢加急性肝衰竭患者短期生存的模型。
BMC Gastroenterol. 2022 Feb 23;22(1):80. doi: 10.1186/s12876-022-02164-6.
5
Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.肝移植前慢加急性肝衰竭临床病程对移植后生存的影响。
J Hepatol. 2020 Mar;72(3):481-488. doi: 10.1016/j.jhep.2019.10.013. Epub 2019 Oct 25.
6
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure.新型 SALT-M 评分可预测慢加急性肝衰竭患者移植后 1 年的死亡率。
J Hepatol. 2023 Sep;79(3):717-727. doi: 10.1016/j.jhep.2023.05.028. Epub 2023 Jun 12.
7
Impact of cirrhosis-related complications on posttransplant survival in patients with acute-on-chronic liver failure.肝硬化相关并发症对慢性肝功能衰竭急性发作患者移植后生存的影响。
Hepatobiliary Pancreat Dis Int. 2023 Feb;22(1):64-71. doi: 10.1016/j.hbpd.2022.09.004. Epub 2022 Sep 10.
8
Dynamic evaluation based on acute-on-chronic liver failure predicts survival of patients after liver transplantation: a cohort study.基于慢加急性肝衰竭的动态评估预测肝移植后患者的生存:一项队列研究。
Int J Surg. 2023 Oct 1;109(10):3117-3125. doi: 10.1097/JS9.0000000000000596.
9
Acute-on-chronic liver failure: clinical course and liver transplantation.急性慢性肝衰竭:临床病程与肝移植
Expert Rev Gastroenterol Hepatol. 2023 Mar;17(3):251-262. doi: 10.1080/17474124.2023.2180630. Epub 2023 Feb 19.
10
Status 1B designation does not adequately prioritize children with acute-on-chronic liver failure for liver transplantation.1B 期状态不足以优先考虑患有慢加急性肝衰竭的儿童进行肝移植。
Liver Transpl. 2022 Aug;28(8):1288-1298. doi: 10.1002/lt.26436. Epub 2022 Apr 25.

引用本文的文献

1
Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study.一种预测慢性乙型肝炎急性肝衰竭移植后1年死亡率的新型预后模型的开发与验证:一项全国性、多中心队列研究。
EClinicalMedicine. 2025 Jul 17;86:103365. doi: 10.1016/j.eclinm.2025.103365. eCollection 2025 Aug.
2
Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions.从60年肝移植中汲取的经验教训:进展、挑战与未来方向。
World J Transplant. 2025 Mar 18;15(1):93253. doi: 10.5500/wjt.v15.i1.93253.
3

本文引用的文献

1
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure.新型 SALT-M 评分可预测慢加急性肝衰竭患者移植后 1 年的死亡率。
J Hepatol. 2023 Sep;79(3):717-727. doi: 10.1016/j.jhep.2023.05.028. Epub 2023 Jun 12.
2
Machine learning-based mortality prediction models using national liver transplantation registries are feasible but have limited utility across countries.基于机器学习的全国肝移植登记处死亡率预测模型是可行的,但在各国的应用效果有限。
Am J Transplant. 2023 Jan;23(1):64-71. doi: 10.1016/j.ajt.2022.12.002. Epub 2023 Jan 11.
3
Handling missing values in machine learning to predict patient-specific risk of adverse cardiac events: Insights from REFINE SPECT registry.
Generalizability of kidney transplant data in electronic health records - The Epic Cosmos database vs the Scientific Registry of Transplant Recipients.
电子健康记录中肾移植数据的可推广性——Epic Cosmos数据库与移植受者科学登记处的比较
Am J Transplant. 2025 Apr;25(4):744-755. doi: 10.1016/j.ajt.2024.11.008. Epub 2024 Nov 15.
4
From prognostication to therapeutics: Four key questions to accelerate the development of therapeutics for patients with acute-on-chronic liver failure.从预测到治疗:加速治疗慢加急性肝衰竭患者治疗方法的四个关键问题。
Am J Transplant. 2024 Nov;24(11):1963-1967. doi: 10.1016/j.ajt.2024.06.007. Epub 2024 Jul 22.
5
Common definitions and variables are needed for the United States to join the conversation on acute-on-chronic liver failure.美国需要共同定义和变量,以便参与到慢性加急性肝衰竭的讨论中。
Am J Transplant. 2024 Oct;24(10):1755-1760. doi: 10.1016/j.ajt.2024.06.021. Epub 2024 Jul 6.
6
Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis.改善慢性肝病和肝硬化护理质量的临床决策支持与电子干预措施。
Hepatology. 2025 Apr 1;81(4):1353-1364. doi: 10.1097/HEP.0000000000000583. Epub 2023 Aug 23.
机器学习中缺失值的处理以预测特定患者不良心脏事件的风险:REFINE SPECT 注册研究的结果。
Comput Biol Med. 2022 Jun;145:105449. doi: 10.1016/j.compbiomed.2022.105449. Epub 2022 Mar 25.
4
OPTN/SRTR 2020 Annual Data Report: Liver.OPTN/SRTR 2020 年度数据报告:肝脏。
Am J Transplant. 2022 Mar;22 Suppl 2:204-309. doi: 10.1111/ajt.16978.
5
A statistical quality assessment method for longitudinal observations in electronic health record data with an application to the VA million veteran program.电子健康记录数据中纵向观测的统计质量评估方法及其在 VA 百万老兵计划中的应用。
BMC Med Inform Decis Mak. 2021 Oct 20;21(1):289. doi: 10.1186/s12911-021-01643-2.
6
Uncovering Clinical Risk Factors and Predicting Severe COVID-19 Cases Using UK Biobank Data: Machine Learning Approach.利用英国生物库数据揭示临床风险因素并预测严重 COVID-19 病例:机器学习方法。
JMIR Public Health Surveill. 2021 Sep 30;7(9):e29544. doi: 10.2196/29544.
7
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.慢性肝病和肝硬化患者感染 SARS-CoV-2 的结果:一项全国 COVID 队列协作研究。
Gastroenterology. 2021 Nov;161(5):1487-1501.e5. doi: 10.1053/j.gastro.2021.07.010. Epub 2021 Jul 18.
8
A Methodology to Generate Longitudinally Updated Acute-On-Chronic Liver Failure Prognostication Scores From Electronic Health Record Data.一种从电子健康记录数据生成纵向更新的慢加急性肝衰竭预后评分的方法。
Hepatol Commun. 2021 Mar 12;5(6):1069-1080. doi: 10.1002/hep4.1690. eCollection 2021 Jun.
9
Quantifying Variation in Treatment Utilization for Type 2 Diabetes Across Five Major University of California Health Systems.量化五个加利福尼亚大学健康系统中 2 型糖尿病治疗利用的变化。
Diabetes Care. 2021 Apr;44(4):908-914. doi: 10.2337/dc20-0344. Epub 2021 Feb 2.
10
Machine learning in liver transplantation: a tool for some unsolved questions?机器学习在肝移植中的应用:解决一些未解决问题的工具?
Transpl Int. 2021 Mar;34(3):398-411. doi: 10.1111/tri.13818. Epub 2021 Feb 4.